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Review
Modulation of apoptosis sensitivity through the
interplay with autophagic and proteasomal
degradation pathways
ME Delgado1,2, L Dyck1,2, MA Laussmann1,2 and M Rehm*,1,2
Autophagic and proteasomal degradation constitute the major cellular proteolysis pathways. Their physiological and
pathophysiological adaptation and perturbation modulates the relative abundance of apoptosis-transducing proteins and
thereby can positively or negatively adjust cell death susceptibility. In addition to balancing protein expression amounts,
components of the autophagic and proteasomal degradation machineries directly interact with and co-regulate apoptosis signal
transduction. The influence of autophagic and proteasomal activity on apoptosis susceptibility is now rapidly gaining more
attention as a significant modulator of cell death signalling in the context of human health and disease. Here we present a
concise and critical overview of the latest knowledge on the molecular interplay between apoptosis signalling, autophagy and
proteasomal protein degradation. We highlight that these three pathways constitute an intricate signalling triangle that can
govern and modulate cell fate decisions between death and survival. Owing to rapid research progress in recent years, it is now
possible to provide detailed insight into the mechanisms of pathway crosstalk, common signalling nodes and the role of multi-
functional proteins in co-regulating both protein degradation and cell death.
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Facts
 Apoptosis susceptibility is modulated by autophagic and
proteasomal activity.
 Pathway interplay converges at core signalling nodes
which modulate Bcl-2 family signalling and initiator
caspase-8 activation.
 Pathway crosstalk is bi-directional, entails positive and
negative feedback loops and previously unknown apoptosis
initiation platforms.
Open Questions
 Will we be able to progress from a qualitative to a
quantitative and kinetic understanding of the signalling
interplay?
 What are the components of the novel apoptosis initiation
platforms and can we exploit these as drug targets?
 Can perturbations in these pathway interplays be asso-
ciated with human pathophysiologies?
A Signalling Triangle of Apoptosis, Autophagy and
Proteasomal Protein Degradation
The core molecular details of apoptosis signal transduction
and its role as a programmed cell death modality have been
described in great detail. Apoptosis eliminates cells primarily
through the activation of proteases of the caspase family,
whereby initiator caspases proteolytically activate execu-
tioner caspases. These in turn disintegrate cellular content
and evoke features characteristic for apoptotic cell death,
such as phosphatidylserine exposure, chromatin condensa-
tion, nuclear fragmentation, cellular shrinkage and membrane
blebbing.1,2 In recent years, it has become apparent that
apoptosis signalling exhibits substantial molecular crosstalk
with pathways controlling the degradation of short- and
long-lived proteins, namely the ubiquitin-proteasome system
(UPS) as well as macroautophagy (hereafter referred to as
autophagy).3,4 Besides the modulation of apoptosis by the
UPS and by autophagic signalling, also direct inter-depen-
dencies and co-regulations exist between these two degrada-
tion pathways. Together, these result in an intricate signalling
triangle that governs and balances cell survival and death
signalling (Figure 1). In the following, we review the current
knowledge on the central signalling features and molecular
interactions associated with these interplays. This entails an
overview of well-established interactions and co-modulations
that can be associated with the three main axes of the
signalling triangle (autophagy–apoptosis, UPS–apoptosis
and autophagy–UPS) and that primarily involve the crosstalk
with apoptosis signalling at the mitochondrial interface
between apoptosis initiation and execution. This is followed
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by an assessment of recent evidence which indicates that the
apoptosis–autophagy–UPS triangle also encompasses a
currently underappreciated and incompletely described sig-
nalling module that regulates the formation of upstream
signalling platforms by which autophagic and UPS activities
are balanced versus apoptosis initiation through the activation
of initiator caspase-8.
Autophagic Signalling and its Interactions with
Apoptosis Signal Transduction
Autophagy typically constitutes a cytoprotective response that
counteracts stresses such as nutrient deprivation or protein
aggregation and, in the case of mitophagy, serves to remove
old or damaged mitochondria that may otherwise cause harm
by the excessive production of reactive oxygen species.
Autophagosomes, double membrane vesicles that enclose
material destined for degradation, form during autophagy and
subsequently fuse with lysosomes. The content of the
resulting autophagolysosomes is then hydrolysed to provide
an intracellular source of nutrients.5 In cytoprotective scenarios,
autophagy may suppress, avert or delay cell death. However,
if autophagy is excessively induced and if autophagic flux
remains elevated over prolonged times, autophagy can
ultimately likewise result in cell death. Such conditions may
also prime cells for apoptosis, as demonstrated, for example,
by enhanced apoptosis sensitivity at conditions of endoplas-
matic reticulum stress.6 The context-dependent role of
autophagy in promoting or antagonising cell death suscept-
ibility therefore needs attention when interpreting the func-
tional role of autophagic features that may manifest in cell
death scenarios.7,8
A well-described molecular interplay between autophagy
and apoptosis manifests at the mitochondrial interface
between apoptosis initiation and execution. This interplay
links anti-apoptotic Bcl-2 family members, which prevent
apoptotic mitochondrial engagement, into the regulation of
autophagic flux through interactions with Beclin-1. Beclin-1 is
one of several protein components required for autophagy
initiation and drives the early steps of autophagosome
formation through its interaction with Vps34, a phosphoinositide
3-kinase.9 Vps34 in turn recruits additional autophagy-related
(Atg) proteins such as Atg3, 4, 5, 7, 10, 12 and 16, and
their interplay coordinates autophagosomal membrane
nucleation and expansion.5 Beclin-1 interacts with anti-
apoptotic members of the Bcl-2 protein family such as Bcl-2,
Bxl-xL and Mcl-1 through its BH3 domain motif, and these
interactions suppress Beclin-1-dependent autophagy initia-
tion10–14 (Figure 2a). Anti-apoptotic Bcl-2 proteins thereby
obtain significant regulatory influence over cellular autophagic
flux. In particular, Mcl-1 is rapidly degraded in response to
nutrient starvation, resulting in Beclin-1 liberation and efficient
autophagy induction.14 Importantly, it was shown that Beclin-1
fails to reciprocally reduce the anti-apoptotic potential of Bcl-2,
demonstrating that the interaction with anti-apoptotic Bcl-2
proteins uni-directionally limits autophagy initiation.15 The
suppression of autophagy can be alleviated by the BH3-only
proteins Bad and BNIP3. Bad and BNIP3 competitively bind to
anti-apoptotic Bcl-2 members promoting apoptosis through
the activation and oligomerisation of Bax and Bak and can
reinstate Beclin-1-driven autophagy (Figure 2a).13,16,17 Similar
to Bad and BNIP3, also synthetic BH3 mimetics such as
ABT-737 and HA14-1 induce autophagy by Beclin-1 liberation
in addition to triggering apoptotic responses.18 Interestingly,
the BH3-only protein Bim, which needs to be phosphorylated
by JNK to become pro-apoptotic, can directly interact with
Beclin-1 and LC8 in its apoptosis-inactive form.19 Bim thereby
suppresses autophagy by retaining Beclin-1 at the dynein
motor complex. Upon nutrient starvation Bim is phosphory-
lated, Beclin-1 is liberated and promotes autophagy19
(Figure 2a). Apoptotic signalling can therefore be accompa-
nied by autophagy induction. Of note, nutrient depletion can
also suppress apoptosis induction. Increases in mTOR
activity upon starvation result in the phosphorylation and
inactivation of Bad.20 Therefore, the nutrient sensing machinery
upstream of autophagosome formation can actively drive or
suppress apoptosis induction through Bim and Bad. As Bcl-2
family members can modulate bioenergetic signalling inde-
pendent of their apoptotic functions,21 the interplay and
regulation between autophagic and apoptotic responses
may be more complex than is currently understood.
Although Beclin-1 does not limit the anti-apoptotic potency
of Bcl-2 family proteins, it can strengthen cell death responses
subsequent to apoptosis initiation. Caspases can cleavage
Beclin-1 and thereby convert it from a pro-autophagic to a pro-
apoptotic protein. The COOH-terminal cleavage fragment of
Beclin-1 integrates into the outer mitochondrial membrane
and promotes cytochrome c release and apoptosis execu-
tion22 (Figure 2a). A similar proteolysis-driven conversion of
function has been described for Atg5, an E3 ubiquitin ligase
component of the LC3 lipidation complex that is required for
autophagosome formation. During apoptosis scenarios that
are associated with calpain activation, calpains cleave Atg5
and the cleavage product antagonises anti-apoptotic Bcl-2
family proteins.23 Together, this highlights a substantial
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interplay between autophagic and apoptotic signalling
through a number of well-characterised molecular interac-
tions. These interactions can modulate the thresholds for
autophagy and apoptosis induction.
The UPS and Interactions with Apoptosis Signal
Transduction
Besides autophagy, the UPS is a second evolutionarily
conserved degradation pathway which likewise is interlinked
with apoptosis signal transduction by co-modulating relation-
ships.4 Proteasomes are multi-protein complexes responsible
for the selective degradation of mostly cytoplasmic proteins,
in particular misfolded and high-turnover proteins.24,25
Proteasomes possess multiple proteolytically active sites that
degrade proteins into peptides with a length of 3–25 amino
acids. Proteins are marked for proteasomal degradation when
covalently labelled with K48-linked poly-ubiquitin chains by
substrate-specific E3 ubiquitin ligases.25 However, non-
canonical ubiquitin-based post-translational modifications
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Figure 2 Crosstalk and interactions in the autophagy–apoptosis and UPS–apoptosis interplays. (a) The major components regulating the interplay of autophagy and
apoptosis at the level of Beclin-1 and Bcl-2 family members are shown. Unphosphorylated Bim forms a complex with Beclin-1 and the adaptor protein LC8. Free Beclin-1 can
be antagonised by anti-apoptotic Bcl-2 family proteins. The latter can be inhibited by phosphorylated Bim and other BH3-only proteins such as Bad and Bnip3, resulting in
liberation of Beclin-1 and induction of autophagy. Phosphorylated Bim can activate Bax and Bak, resulting in caspase activation and apoptosis execution. Beclin-1 can be
cleaved by effector caspases and is thereby converted to a pro-apoptotic protein. The interaction of positive and negative regulatory processes therefore determines the
induction of autophagy and/or apoptosis. (b) The main processes and players involved in the control and modulation of apoptosis by proteasomal activity are displayed. (i) The
steady state expression amounts of both pro- and anti-apoptotic proteins are co-regulated by proteasomal activity. Pro-apoptotic proteins that are strongly regulated include
Bax and the BH3-only proteins Bim, Noxa and Bik, anti-apoptotic proteins include Mcl-1, cFLIP and cIAPs. (ii) Inhibition of proteasomal activity disturbs the steady state. As a
consequence, high turn-over proteins accumulate. In addition, proteasome inhibition can actively induce the expression of pro-apoptotic proteins. Proteasome inhibition can
induce apoptosis and is accompanied by compensatory induction of autophagy
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that target proteins for proteasomal degradation have been
described as well.26 The steady-state expression amounts of
various pro- and anti-apoptotic proteins, such as high-
turnover BH3-only proteins Bik, Bim and Noxa and also Bax,
Mcl-1, cFLIP species or cIAPs are strongly influenced by
changes in proteasomal activity27–32 (Figure 2b). Changes in
the activity and in the selectivity of the ubiquitin-labelling and
proteolytic machinery of the UPS therefore provide the
possibility to swiftly increase or decrease apoptosis respon-
siveness. For example, the accumulation of cFLIP species
can delay or prevent caspase-8 activation during extrinsic
apoptosis,32,33 Mcl-1 is degraded upon interleukin-3 with-
drawal and increases cell death susceptibility,34 and BH3-only
protein Bim-EL accumulates upon proteasome inhibition to
trigger the intrinsic apoptosis pathway.35 During apoptosis,
executioner caspases cleave and inactivate the protea-
some,36 thereby stabilising pro-apoptotic proteins such as
cytosolic Smac, BH3-only proteins and active caspases.
In addition, the prolonged inhibition of the proteasome in itself
can induce apoptosis by active transcriptional responses such
as p53-dependent and -independent upregulations of BH3-
only proteins and by the parallel suppression of NFkB-
dependent survival signalling through IkBa stabilisation37,38
(Figure 2b). Proteasome inhibitors also synergistically
enhance the susceptibility to various intrinsic and extrinsic
apoptosis stimuli in co-treatment scenarios.39,40 The interplay
between the UPS and apoptosis is therefore complex and,
depending on the signalling context, UPS activity can
enhance or reduce apoptosis susceptibility.
Interplay of Autophagic and Proteasomal Protein
Degradation Pathways
Besides the interplay of autophagy and the UPS with
apoptosis signal transduction, significant co-modulation and
crosstalk exists also between autophagic and UPS signalling
at the level of substrate labelling and recognition. Ubiquitin
has a central role in this interplay due to its dual functionality in
channelling substrates either through proteasomal or auto-
phagic degradation. Although K48 ubiquitin chains target
labelled proteins for proteasomal degradation, K63-linked
ubiquitin chains direct proteins towards autophagy-dependent
lysosomal degradation.41 A dual functionality that carries
relevance for both proteasomal and autophagic degradation
pathways has also been observed at the level of E3 ubiquitin
ligases, with the E3 ligase CHIP being capable of generating
both K48- and K63-linked ubiquitin chains.42 Although this
already indicates that autophagic and proteasomal flux can be
cross-modulated, the ubiquitin binding protein and autophagy
receptor p62/SQSTM1 exerts further control on this interplay.
p62/SQSTM1 effectively binds to K63-ubiquitin chains to
shuttle labelled proteins towards autophagic degradation.
However, p62/SQSTM1 also binds K48 ubiquitin chains,
albeit with lower affinity.43 Although it was reported that p62/
SQSTM1 can assist in channelling substrates through the
proteasomal degradation pathway,44 it also delays or reduces
proteasomal degradation of short-lived proteins, including cell
death regulator p53, when accumulating excessively as a
consequence of autophagy inhibition.45,46 It was suggested
that the inhibition of proteasomal flux might arise from two factors.
First, p62/SQSTM1-associated protein aggregates may
become too bulky for proteasomal degradation and, second,
high amounts of p62/SQSTM1 may outcompete other
ubiquitin binding proteins that promote efficient proteasomal
protein degradation.47 Overall, the influence of p62/SQSTM1
at the interface of autophagy and proteasomal degradation
therefore appears substantial. In contrast, an inhibition of
autophagy is not observed when inhibiting the UPS. Rather,
proteasome inhibition results in increased steady-state levels
of p62 and elevated autophagic flux,48,49 indicating that cells
may actively respond to compensate for impaired UPS
function.
The Interplay of Autophagic and Proteasomal Activities
Controls Lethal and Non-lethal Caspase-8 Activation
Although the interplay of apoptosis with autophagy and the
UPS at the mitochondrial interface between apoptosis
initiation and execution has been described in great detail,
several recent studies have demonstrated that so far poorly
characterised signalling platforms may form upstream or in
parallel to this interplay. These platforms promote the
activation of initiator caspase-848,50,51 (Figure 3). Although
the apical activation of caspase-8 may have implications for
apoptosis initiation signalling, these platforms could also be
involved in regulating non-lethal caspase-8 activities that
could be relevant for cellular proliferation and differentiation.52
Caspase-8 is predominantly known as the primary initiator
caspase of the extrinsic apoptosis pathway that is triggered by
death ligands binding to their respective cell surface receptors.
The activation of caspase-8 in the context of proteasome
inhibition and autophagic signalling instead occurs indepen-
dently of death ligands on an alternative intracellular activation
platform.48,51 Caspase-8 appears to contribute substantially
towards the potency of proteasome inhibitors in eliminating
human cancer cells, in particular those that express high
amounts of anti-apoptotic Bcl-2 family proteins.48,50 Caspase-8
activation upon proteasome inhibition requires FADD, an
adaptor protein that is also required for procaspase-8
aggregation and activation during extrinsic apoptosis, and
also depends on the induction of autophagy.48 Inhibition of
autophagy by the PI3K-inhibitor 3-methyl adenine or inhibition
of autophagosome formation by Atg5 deletion significantly
reduce caspase-8 activation and apoptotic responses upon
proteasome inhibition.48,51 In this context, it is interesting to
note that FADD was previously shown to bind to Atg5 in vitro
and in vivo in a study that investigated cell death regulation in
response to interferon g.53 In addition to FADD and Atg5,
microtubule-associated protein 1 light chain 3 (LC3) and p62/
SQSTM1 further promote caspase-8 activation upon
proteasome inhibition.50 p62/SQSTM1 accumulates upon
proteasome inhibition,48 and p62/SQSTM1 has previously also
been shown to promote the efficient activation of poly-
ubiquitylated caspase-8 during canonical extrinsic apopto-
sis.54 A recent study further supports the role of p62/SQSTM1
in promoting caspase-8-dependent apoptosis in scenarios of
autophagy induction in co-treatment scenarios with protea-
some inhibitors.55 p62/SQSTM1 may therefore be a molecular
link that not only has a role in the interplay between UPS and
autophagy, but also co-regulates caspase-8 activation both
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during extrinsic caspase-8-dependent apoptosis and during
intrinsic scenarios of apical caspase-8 activation.
Interestingly, it was reported that cellular FLICE inhibitory
protein (cFLIP), an inactive caspase-8 homologue, can bind to
Atg3, an E2-like conjugating enzyme for LC3. cFLIP thereby
prevents LC3I-II conversion and limits autophagy induction
and autophagic flux.56 cFLIP is known to accumulate upon
proteasome inhibition, and we have previously demonstrated
that even though proteasome inhibition induces autophagy,
LC3-I is inefficiently converted to LC3-II.48 This indicates that
cFLIP may limit increases in autophagic flux following
proteasome inhibition. It can be speculated that because of
the structural similarities to cFLIP also caspase-8 may interact
with Atg3, but experimental proof so far is missing. Never-
theless, similar to the loss of Atg5, also Atg3 deficiency
reduces caspase-8 activity, indicating that it has a role in the
activation process and probably is an important part of the
activation platform. As Atg3 can be cleaved by caspases,
probably including caspase-8,57 Atg3 cleavage may further
reduce overall autophagic flux and could contribute to
establishing an additional layer of control at the interface of
autophagy and apoptosis induction. Of note, it has been
reported that during canonical extrinsic apoptosis induction
active caspase-8 is eliminated by autophagy.58 Limiting
autophagic flux in parallel to or directly by caspase-8
activation could therefore also be a prerequisite to maintain
caspase-8 activities for prolonged times.
An autophagy-dependent activation of caspase-8 was also
reported in response to sphingosine kinase inhibition.51
However, it is currently unclear whether sphingosine kinase
inhibition generally triggers autophagy and whether apoptosis
is the dominant resulting cell death modality. The observed
responses appear to depend substantially on the chosen
experimental system.59,60 Another report demonstrated that
glucose starvation can trigger caspase-8 activation.61
Although the underlying molecular mechanism has not yet
been identified, glucose deprivation is known to potently
induce autophagic responses. A similar signalling scenario
therefore may be implicated in this condition. Interestingly,
interaction complexes between FADD and Atg5-12 that drive
caspase-8 activation have also been reported in proliferating
T cells.62 Here, caspase-8 activity was shown to limit
autophagic flux and thereby to contribute to cell survival.
T cell death in absence of caspase-8 activity could be prevented
by inhibition of RIP kinase 1 by necrostatin, indicating a role for
necroptosis in shaping T-cell populations. Although the
interplay of necroptosis and apoptosis and their dependence
on caspase-8 and RIP kinase signalling has been further
elucidated in the meantime,63 it needs to be noted that RIP-
mediated necroptosis appears not to contribute to cancer cell
death in response to proteasome inhibition.48 However,
cancer cells frequently appear to lack expression of the
crucial RIPK1 substrate and downstream necroptosis med-
iator RIPK3.64 RIPK1 was also reported to be part of
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Figure 3 Proposed components and composition of a caspase-8 activation platform that forms as a signalling node in the interplay of apoptosis, autophagy and the UPS.
On the basis of the accumulated experimental evidence of a number of recent studies, the molecular composition and formation mechanism for a novel caspase-8 activation
platform is proposed. The formation of the activation platform requires the interplay of a number of Atg proteins and LC3 as well as core proteins that are relevant also during
extrinsic apoptosis induction (Fadd, cFLIP, caspase-8). Lipidated LC3II, together with Atg5-12, Atg16, Fadd and p62 appear to contribute to caspase-8 activation and may
form a multi-molecular activation platform on autophagosomal membranes. Details on these interactions and their implications for caspase-8 activation and apoptosis
induction are provided in the text
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non-canonical caspase-8 activation complexes, termed ripop-
tosomes, that form in response to genotoxic stress or during
innate immune responses, in particular when IAPs are
depleted.65,66 RIPK1 activity is required for the formation of
these complexes, and proteasome inhibition further enhances
caspase-8 activation on ripoptosomes.65,66 However, ripopto-
somes contain only a fraction of the total cellular caspase-8
pool,65,66 and the potency of proteasome inhibitors in inducing
apical caspase-8 processing appears to be significantly
higher than what can be achieved with genotoxic drugs such
as 5-fluorouracil or cisplatin.48 It is therefore currently unclear
whether proteasome inhibition enhances casapase-8 activa-
tion upon genotoxic stress by a more efficient formation
of ripoptosomes or rather by inducing an independent
autophagy-associated response of caspase-8 activation as
described above.
Conclusions and Perspectives
We here described and discussed the most central aspects
of the interplay of apoptosis signalling, autophagy and
proteasomal protein degradation. This interplay is complex
and provides a multi-factorial control over the modulation
of apoptosis susceptibility and cell fate decisions between
death and survival. Of note, the currently published
data indicate that this modulation appears to manifest
predominantly through interactions with the apoptosis initia-
tion network. With the exception of the multifunctional
caspase inhibitor x-linked inhibitor of apoptosis protein
that has now been described to possess an autophagy
suppressor function,67 components of apoptosis execution
signalling so far have not been implicated as central
regulators of this interplay. However, as effector caspases
cleave and thereby inactivate or functionally transform
critical components of the autophagy and UPS signalling
systems,22,36,68 downstream feedbacks from drivers of
apoptosis execution may significantly contribute towards
ensuring strict and efficient cell death decisions by attenuating
proteasomal and autophagic fluxes.
Although a number of recent studies provide evidence
which points out that caspase-8 is a central player that links
autophagy-UPS signalling to apoptosis signal transduction,
further fundamental studies will be required to elucidate and
understand the control and regulation of this interplay at the
molecular level. For example, even though some key
components required for caspase-8 activation in these
scenarios are known, information on their stoichiometry within
the caspase-8 activation platforms is not available. Quantita-
tive biochemical and structural biological studies were
successfully conducted in recent years to determine the
relative protein abundances and quaternary structures of
caspase-8 activation platforms during canonical extrinsic
apoptosis initiation.69–71 Adapted accordingly, further insight
into the molecular mechanisms of alternative modes of
caspase-8 activation, and their control by autophagic and
proteasomal flux can be expected in the future. Besides the
molecular composition of such caspase-8 activation plat-
forms, also the regulation of post-translational modifications
will likely constitute an additional layer of control. Experi-
mental evidence indicates that posttranslational control over
extrinsic, DISC-dependent caspase-8 activation encom-
passes glycosylation, nitrosylation, ubiquitylation, and phos-
phorylation, and that these modifications can be
physiologically and pathophysiologically relevant.72,73 For
example, it is well established that caspase-8 can be
phosphorylated on conserved tyrosine residues by several
kinases, including Src kinases, to prevent or delay its
activation during extrinsic apoptosis.74,75 Interestingly, Src
kinase can be eliminated by autophagy.76 It therefore appears
to be warranted to further investigate whether the autophagic
elimination of Src kinase activity is required to allow an
efficient activation of caspase-8 activation on autophagoso-
mal membranes. In general, investigations taking into account
posttranslational modifications therefore could provide further
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important insight into the modulation of caspase-8 activation
and the interplay of apoptosis initiation with proteasomal and
autophagic degradation pathways. As caspase-8 cleaves and
activates the Bcl-2 family protein Bid, the modulation of
apoptosis initiation through the formation of caspase-8 on
non-canonical activation platforms (Figure 3) will also need to
be investigated in the context of the co-regulation of protein
degradation pathways and apoptosis initiation at the level of
Bcl-2 family proteins (Figure 2).
As the work discussed here has shown, the consequences
of perturbed autophagic or proteasomal signalling on apop-
tosis susceptibility can be ambiguous (Figure 4). Care
therefore needs to be taken when investigating and interpreting
experimental data on causes and effects in these scenarios.
In particular, generalised statements on whether apoptosis
susceptibility will be enhanced or decreased by modulating
the main cellular proteolytic pathways may not be warranted.
Translational and clinical studies investigating the role of
autophagic signalling in cancer have already highlighted that
whether autophagy promotes or inhibits cancer development
and progression must be assessed individually for each
scenario under investigation.77 For example, autophagy is
required for tumour growth in pancreatic cancers,78 whereas
in early-stage cutaneous melanoma higher levels of
autophagy correlate with prolonged progression-free survival
times.79 Besides these examples, deregulations in autopha-
gic signalling and in the UPS have widely been associated
with human pathophysiologies, including neurode-
generative diseases, cardiovascular diseases, and infectious
diseases.80–82 In the light of these findings, further research
on the interplay of autophagy and the UPS with cell death
signalling pathways will likely be highly relevant to understand
how the respective disease phenotypes are established.
A detailed understanding of these interplays may
therefore allow us to associate quantitative information on
pathway crosstalks and activities with pathophysiological
consequences. Ultimately, this may serve to devise novel
targeted interventions that therapeutically may be broadly
applicable.
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